Gossamer Bio, Inc. — Director's Dealing 2019

Feb 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2019-02-12

Reporting Person: Giraudo Bryan (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-12	Common Stock	C	17879	—	Acquired	17879	Direct
2019-02-12	Common Stock	P	6000	$16.00	Acquired	23879	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-12	Series A Preferred Stock	$	C	57142	Disposed		Common Stock (12698)	Direct
2019-02-12	Series B Preferred Stock	$	C	23316	Disposed		Common Stock (5181)	Direct

Footnotes

F1: The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date.